Md. Rafat Tahsin | Phytopharmacology | Research Excellence Award

Published on by Cell Biologist

Mr. Md. Rafat Tahsin | Phytopharmacology | Research Excellence Award

Endoplasmic Reticulum Bangladesh | Bangladesh

An accomplished researcher in phytopharmacology and genetic polymorphism with a strong academic foundation in pharmacy and pharmacology. Actively engaged in multidisciplinary research integrating in vivo, in vitro, and in silico approaches to evaluate plant-derived bioactive compounds for therapeutic applications, particularly in diabetes, hyperlipidemia, hepatoprotection, and neuropharmacology. Contributed to multiple peer-reviewed publications in indexed journals, demonstrating expertise in experimental design, data analysis, and scientific writing. Current work includes hypothesis-driven research on overcoming genetic polymorphism challenges through engineered plant-based solutions, supporting advancements in personalized medicine. Also involved in collaborative research initiatives and training in research methodology and manuscript development.

Citation Metrics (Scopus)

100
80
60
40
20
10
0

Citations
61

Documents
11

h-index
5

Citations

Documents

h-index

Featured Publications

Shola Omoseeye | Bioinformatics | Young Scientist Award

Published on by Cell Biologist

Mr. Shola Omoseeye | Bioinformatics | Young Scientist Award

Ekiti state university, Ado Ekiti. | Nigeria

Aspiring bioinformatics and molecular biology researcher with a strong foundation in computational drug discovery, genomics, and cancer research. Holds a B.Sc. in Anatomy with upper-class honors, demonstrating expertise in neuroanatomy, genetics, and tissue analysis. Experienced in molecular docking, protein modeling, gene expression studies, and laboratory techniques including PCR and ELISA. Skilled in data analysis using SPSS, GraphPad Prism, and Excel, and proficient in scientific software for drug design. Contributed to multiple peer-reviewed publications and mentored undergraduate students in bioinformatics. Active in teaching, research assistance, and professional scientific organizations, committed to advancing translational research in molecular medicine.

Featured Publications

Rahul Kumar | Pharmaceutical Chemistry | Research Excellence Award

Published on by Cell Biologist

Mr. Rahul Kumar | Pharmaceutical Chemistry | Research Excellence Award

Vidya University, Meerut | India

A dedicated academic and research-oriented professional in pharmaceutical sciences with specialization in Computer-Aided Drug Design (CADD) and Pharmaceutical Chemistry. Possesses strong expertise in drug discovery workflows, molecular modeling, QSAR analysis, molecular dynamics simulations, and computational approaches to rational drug design. Actively engaged in teaching and mentoring at the undergraduate and postgraduate levels, with a commitment to innovative pedagogy and outcome-based education. Research interests align with interdisciplinary applications of computational chemistry to address challenges in modern healthcare and drug development. Demonstrated academic excellence through recognition at national and international research forums, including awards in health science research competitions. Actively participates in professional development through workshops and training programs focused on CADD, QSAR, molecular dynamics, and intellectual property awareness. Committed to advancing pharmaceutical education, fostering research culture, and contributing to translational science that bridges computational research with experimental and clinical applications.

Featured Publications


Designing Aptamers for Cancer Diagnosis Therapy

– Biosensors and Aptamers: A New Era in Cancer Diagnosis and Treatment, 2025 | Book Chapter

Integrating Small Molecules into Multimodal Treatment Strategies

– Small Molecules in Neurodegeneration, 2025 | Book Chapter

Recurrent Pregnancy Loss: Immunogenetic Factors, Clinical Implications, Diagnostic Approaches, and Future Perspectives

– Reproductive Immunogenetics: A Molecular and Clinical Overview, Vol. 3, 2025 | Book Chapter

Shaibal Chandra | Pharmacology | Editorial Board Member

Published on by Cell Biologist

Mr. Shaibal Chandra | Pharmacology | Editorial Board Member

Bengal School of Technology | India

Shaibal Chandra is an Assistant Professor of Pharmacology with strong academic training and research expertise in experimental and translational pharmacology. His teaching portfolio spans core and advanced subjects including Pharmacology, Human Anatomy and Physiology, Pathophysiology, Microbiology, Advanced Pharmacology, and Pharmaceutical Screening Methodology. His research interests focus on phytopharmacology, antioxidant and antiurolithiatic studies, CNS pharmacology, antifertility activity, immunopharmacology, and nano-based therapeutic approaches. He has conducted in vivo pharmacological evaluations using established animal models and possesses hands-on expertise in animal handling, biochemical assays, microscopic techniques, and laboratory instrumentation. His postgraduate research investigated the antiurolithiatic potential of metformin in ethylene glycol-induced renal stone models. He has authored multiple peer-reviewed research and review articles in national and international journals, contributed book chapters published by reputed academic publishers, and holds a published patent related to green nanoparticle synthesis with antioxidant and antibacterial applications. He actively participates in national and international scientific conferences through poster and e-poster presentations, including work on cancer immunotherapy and nanostructure-based drug delivery. He has also served as a reviewer for international journals and supervised undergraduate and postgraduate research projects, reflecting sustained engagement in academic research and mentorship.

Profile: Orcid

Featured Publications:

Chandra, S., & Chowdhury, S. (2025). Systemic effect of different physiological parameters associated with mirror syndrome. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.70062

Chandra, S., Mondal, N., Chatterjee, A., & Tapadar, D. (2025). Exploration of antiurolithiatic properties of methanolic extract of rhizome of Cyperus tegetum Roxb. in ethylene glycol-induced urolithiatic rats. Pharmacological Research – Natural Products, 100181. https://doi.org/10.1016/j.prenap.2025.100181

Chandra, S. (2024). Phytochemical and pharmacological (CNS) screening of alcoholic extract obtained from Melia azedarach (leaf). Bengal School of Technology (A College of Pharmacy).

Kar, D. R., Dutta, A., Chandra, S., Das, P. P., & Paul, D. K. (2023). Evaluation of the antifertility activity of methanolic extract of Melia azedarach and their GC–MS study. International Journal of Pharmaceutical and Phytopharmacological Research, 13, 201–220. https://doi.org/10.51847/bxeo6u8vnk

Chakraborty, M., Das, P. P., Chandra, S., Shaharyar, M. A., Sarkar, N., Mukherjee, S., Paul, S., Bhowmik, R., Haldar, P. K., & Karmakar, S. (2023). Toxicology of nanoformulations and materials in tissue engineering. In Nanostructured materials for tissue engineering. Elsevier. https://doi.org/10.1016/B978-0-323-95134-0.00006-7

Chandra, S. (2023). Antidiabetic activity of exotic Indian spices. In Medicinal spices and herbs from India. Apple Academic Press (CRC Press).

minghe luo | Microbial Cell Biology | Best Researcher Award

Published on by Cell Biologist

Mr. minghe luo | Microbial Cell Biology | Best Researcher Award

Mr. minghe luo , Chongqing University of Technology , China

Dr. Minghe Luo, born in April 1984, is an accomplished pharmaceutical scientist and Associate Professor at Chongqing University of Technology. Specializing in natural product biosynthesis, he has made significant contributions to the discovery of novel antibiotics and the mechanistic understanding of biosynthetic pathways from marine microorganisms. His academic journey has taken him through respected institutions including Wuhan University and Southwest University, with extensive research training at the South China Sea Institute of Oceanology. Known for his collaborative spirit and deep expertise in medicinal chemistry, Dr. Luo has authored numerous impactful publications in journals like Angewandte Chemie and Organic Letters. His work not only advances scientific knowledge but also offers practical implications for antibiotic development. A dedicated educator and researcher, Dr. Luo continues to explore microbial biosynthetic machinery, aiming to discover new therapeutics for drug-resistant infections.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Depth of Expertise:
    Dr. Luo has solid academic foundations with a PhD in Pharmacy and a Master’s in Medicinal Chemistry of Natural Products. His specialty in natural products biosynthesis—particularly from marine microorganisms—positions him uniquely in pharmaceutical research.

  2. Research Output & Impact:
    He has authored over 15 research papers in high-impact journals such as Angewandte Chemie, Organic Letters, Chemical Engineering Journal, and Journal of Natural Products. His work tackles urgent global needs, like antibiotic resistance, with research on compounds targeting MRSA and other drug-resistant pathogens.

  3. Innovation in Biosynthesis:
    His research on trans-AT polyketide synthases, novel biosynthetic pathways, and genome mining for cryptic natural products exemplifies forward-thinking, interdisciplinary science.

  4. Independent Research and Teaching:
    As an Associate Professor, he leads independent projects while teaching and mentoring students—demonstrating both leadership and academic service.

  5. Collaboration:
    His co-authored papers reflect strong collaborative ties, including with international researchers like Prof. Jeroen Dickschat (Germany), a mark of scientific credibility and connectivity.

⚠️ Areas for Improvement:

  1. Patent/Translational Outputs:
    While his publications are excellent, showcasing patents, industry collaborations, or drug development pipelines would better demonstrate translational relevance.

  2. Global Outreach:
    Participation in international conferences, scientific boards, or as an editorial reviewer could enhance his global visibility.

  3. Public Engagement:
    Greater involvement in public science communication or outreach could boost his societal impact profile.

🎓 Education:

Dr. Minghe Luo earned his Doctorate in Pharmacy from Wuhan University (2018–2021), under the supervision of Prof. Yuhui Sun, focusing on the biosynthesis of natural products. Prior to this, he completed a Master’s degree in Medicinal Chemistry of Natural Products through a joint program between Southwest University and the South China Sea Institute of Oceanology (2008–2011), guided by Professors Zichuan Bai and Jianhua Ju. His postgraduate training emphasized the chemical characterization and bioactivity of marine-derived fungal metabolites. This unique blend of pharmacy and chemistry, alongside rigorous experimental research, laid the foundation for his expertise in microbial natural product discovery and biosynthesis. Dr. Luo’s academic development reflects a deep commitment to both theoretical understanding and applied research, equipping him with the tools to lead investigations into novel bioactive compounds, particularly those from extreme marine environments.

💼 Experience:

Dr. Luo began his career as a research scientist at the Third Affiliated Hospital of the Third Military Medical University (2011–2018), focusing on microbial natural product discovery. In 2021, he joined Chongqing University of Technology as an Associate Professor, where he leads independent projects on biosynthetic pathway elucidation and engineering of marine microbial metabolites. His role includes teaching pharmacy courses and mentoring graduate students. Dr. Luo’s experience spans isolation, structural elucidation, and genetic manipulation of microbial strains to unlock cryptic biosynthetic potential. His consistent publication record demonstrates both foundational research and innovative biosynthetic strategies. Over the years, he has cultivated a reputation for high-quality research and collaborative spirit, contributing significantly to antibiotic and anticancer compound discovery pipelines. He is particularly recognized for exploring deep-sea actinomycetes, making meaningful strides in developing novel antibacterial agents against drug-resistant pathogens.

🔬 Research Focus:

Dr. Luo’s research centers on the biosynthesis of microbial natural products, particularly from marine-derived actinomycetes and fungi. His primary interests include identifying novel polyketides, non-ribosomal peptides, and hybrid metabolites with antibacterial or anticancer potential. He employs genome mining, biosynthetic gene cluster (BGC) characterization, and pathway engineering to discover and optimize the production of bioactive compounds. A key theme in his work is understanding the mechanisms of tailoring enzymes (e.g., methyltransferases, P450s, dehydrating modules) that diversify natural product structures. Dr. Luo has also made major strides in elucidating biosynthetic pathways like those for hangtaimycin and streptovaricins. He is passionate about translating his findings into new drug leads, particularly targeting MRSA and multi-drug-resistant infections. His interdisciplinary approach bridges organic chemistry, synthetic biology, and pharmacology, contributing to the broader field of drug discovery from marine natural sources.

📚 Publications Top Notes:

  1. 🧪 The mechanism of dehydrating bimodules in trans-AT polyketide biosynthesis: hangtaimycin study – Angew. Chem. Int. Edit.

  2. 🧬 Methylation in hangtaimycin biosynthesis and its antibacterial activities – Synth. Syst. Biotechnol.

  3. 💊 Local delivery of deep marine equisetin via PVP nanofibers for anti-MRSA – Chem. Eng. J.

  4. 🌊 Natural siderophore acremonpeptides and their aluminum complex from Acremonium – J. Nat. Prod.

  5. 🔬 Amino acid-conjugated anthraquinones from marine Penicillium sp. – J. Nat. Prod.

  6. 🌐 Halogenated anthraquinones from Aspergillus sp. – J. Nat. Prod.

  7. 🧫 Genome-based mining of carpatamides I–M and their biosynthetic gene cluster – Mar. Drugs

  8. 🌿 Antibacterial lobophorin L and M from marine Streptomyces sp. – Nat. Prod. Res.

  9. 🧪 Two new streptovaricin derivatives from Streptomyces spectabilis mutants – Nat. Prod. Res.

  10. ⚗️ Mycophenolic acid derivative from Penicillium sp. fermentation – Nat. Prod. Res.

🧾 Conclusion:

Dr. Minghe Luo clearly exhibits the scientific rigor, innovation, and productivity deserving of the Best Researcher Award. His contributions to the field of natural product chemistry and biosynthesis, especially in the context of antimicrobial resistance, are both timely and impactful. With minor improvements in translational output and international visibility, he is poised to become a leading figure globally in pharmaceutical biotechnology.

Arvind Singh Negi | Medicinal chemistry | Outstanding Scientist Award

Published on by Cell Biologist

Dr. Arvind Singh Negi | Medicinal chemistry | Outstanding Scientist Award

Dr. Arvind Singh Negi  , csir-cimap , India

Dr. Arvind Singh Negi, born on January 1, 1970, is a prominent scientist in the field of medicinal chemistry, currently serving as Chief Scientist and Head of the Phytochemistry Division at CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India. With a distinguished academic background and over three decades of experience, he specializes in natural product chemistry and the development of cancer chemotherapeutics. Dr. Negi has published extensively, contributing significantly to the understanding of plant-based medicinal compounds. His work has garnered numerous accolades, reflecting his commitment to advancing science in medicinal chemistry and natural products.

Publication Profile

Google Scholar

Strengths for the Award

Dr. Arvind Singh Negi possesses a robust academic background and extensive experience in medicinal chemistry, particularly in the development of cancer therapeutics from natural products. His impressive publication record, with over 106 research papers and significant citations, showcases his impact on the field. His leadership as Chief Scientist at CSIR-CIMAP reflects his ability to drive innovative research initiatives. Additionally, his multiple prestigious awards and fellowships, including recognition from the Royal Society of Chemistry and the National Academy of Sciences, underscore his scientific contributions and collaborations on a global scale.

Areas for Improvement

While Dr. Negi’s research achievements are commendable, expanding his outreach to interdisciplinary collaborations could enhance the applicability of his findings. Increasing engagement in public awareness and education on the significance of his research in medicinal chemistry could also strengthen his influence beyond academic circles. Further diversification of research themes might attract funding and foster novel explorations in related areas.

Education 

Dr. Negi completed his B.Sc. in Physics, Chemistry, and Mathematics from Lucknow Christian Degree College, University of Lucknow, in 1989. He excelled academically, earning his M.Sc. in Chemistry with First Rank from the same university in 1991. He further pursued a Ph.D. in Medicinal Chemistry at CSIR-Central Drug Research Institute, obtaining his degree in 1999. His educational journey includes significant research experiences, starting as a Scientist at ICAR-Indian Grassland and Fodder Research Institute in 1995. Dr. Negi has continuously advanced his knowledge and expertise through various fellowships, including prestigious opportunities at renowned international institutions, shaping his specialization in organic and natural product chemistry.

Experience 

Dr. Arvind Singh Negi boasts over 25 years of research experience in the field of medicinal chemistry. He began his career as a Scientist at ICAR-Indian Grassland and Fodder Research Institute in 1995, moving on to join CSIR-CIMAP in 2000. Over the years, he has progressed through various ranks, becoming a Chief Scientist in 2018. His extensive experience encompasses research and development of natural product-based pharmaceuticals, focusing on cancer therapeutics and organic synthesis. Dr. Negi has also supervised multiple Ph.D. theses and collaborated with national and international researchers, contributing to over 100 research publications. His leadership in the Phytochemistry Division has fostered innovative research projects, enhancing the institute’s reputation in medicinal plant research.

Awards and Honors 

Dr. Negi’s exemplary contributions to science have been recognized through numerous awards and honors. He was awarded the CSIR-JRF and Lectureship in 1991, followed by the ICAR Assistant Professorship in 1994. His research has earned him the Bioorganic & Medicinal Chemistry Most Cited Paper Award three times (2007, 2008, 2010) from Elsevier Press. He has received prestigious fellowships, including the ICS-UNIDO Fellowship in Italy (2008) and the Raman Research Fellowship in the USA (2010). Dr. Negi became a member of the National Academy of Sciences (NASI) in 2013 and was later invited to the Royal Society of Chemistry, achieving Fellow status in 2022. His recognition underscores his significant impact on medicinal chemistry and natural product research.

Research Focus 

Dr. Arvind Singh Negi specializes in medicinal chemistry, with a primary focus on the development of cancer chemotherapeutics. His current research involves designing target-specific molecules to modulate microtubule dynamics, a crucial aspect of cancer treatment. By harnessing the therapeutic potential of natural products, he investigates plant-based compounds that exhibit anticancer properties. His work encompasses extensive studies on the chemical and biological profiles of medicinal plants, contributing to the discovery of novel anticancer agents. Dr. Negi’s innovative approaches aim to bridge the gap between traditional knowledge and modern scientific methodologies, making significant strides in the field of phytochemistry. His research not only enhances our understanding of cancer therapeutics but also promotes the exploration of sustainable and effective treatments derived from nature.

Publication Top Notes

  1. Plant-based anticancer molecules: A chemical and biological profile of some important leads 🌱
  2. Antimicrobial potential of Glycyrrhiza glabra roots 🌿
  3. Recent advances in plant hepatoprotectives: a chemical and biological profile of some important leads 🌿
  4. Current status on development of steroids as anticancer agents 💊
  5. Antifungal activity of Glycyrrhiza glabra extracts and its active constituent glabridin 🌿
  6. Gallic acid-based indanone derivatives as anticancer agents 🌿
  7. Synergistic anticandidal activity of pure polyphenol curcumin I in combination with azoles and polyenes generates reactive oxygen species leading to apoptosis 🌿
  8. Natural antitubulin agents: Importance of 3, 4, 5-trimethoxyphenyl fragment 🌱
  9. Synthesis of chalcone derivatives on steroidal framework and their anticancer activities 💊
  10. Synthesis of 1-(3′,4′,5′-trimethoxy) phenyl naphtho[2,1b]furan as a novel anticancer agent 🌱
  11. Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine 🌱
  12. An insight into medicinal chemistry of anticancer quinoxalines 💊
  13. Antitubercular potential of some semisynthetic analogues of phytol 🌱
  14. Defective in cuticular ridges (DCR) of Arabidopsis thaliana, a gene associated with surface cutin formation, encodes a soluble diacylglycerol acyltransferase 🌱
  15. Nutritive evaluation of some nitrogen and non-nitrogen fixing multipurpose tree species 🌳
  16. Antiproliferative and antioxidant activities of Juglans regia fruit extracts 🌰
  17. Synthesis of pharmacologically important naphthoquinones and anticancer activity of 2-benzyllawsone through DNA topoisomerase-II inhibition 💊
  18. A bioactive labdane diterpenoid from Curcuma amada and its semisynthetic analogues as antitubercular agents 🌿
  19. Anticancer activity and toxicity profiles of 2-benzylidene indanone lead molecule 💊
  20. A promising anticancer and antimalarial component from the leaves of Bidens pilosa 🌿

Conclusion

Dr. Arvind Singh Negi is an exemplary candidate for the Outstanding Scientist Award. His pioneering work in medicinal chemistry, along with his dedication to advancing cancer therapeutics through innovative research, positions him as a leader in the field. With strategic enhancements in collaboration and outreach, his impact could extend even further, benefiting both scientific communities and public health.